Navigation Links
Arena Pharmaceuticals' Lorcaserin for Obesity Passes Major Safety Milestone
Date:3/17/2008

- Month-12 Independent Echocardiographic Data Safety Monitoring Board Review Strengthens Lorcaserin's Emerging Cardiovascular Safety Profile -

SAN DIEGO, March 17 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that following a planned review by an independent Echocardiographic Data Safety Monitoring Board (EDSMB) it is continuing BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management), a pivotal trial evaluating the efficacy and safety of lorcaserin hydrochloride for the treatment of obesity. The EDSMB's review of unblinded echocardiographic data performed after patients completed 12 months of dosing in the trial confirmed that differences, if any, in the rates of Food and Drug Administration (FDA)-defined valvulopathy in patients treated with lorcaserin and in the control group did not meet the EDSMB's predetermined stopping criteria. Based on the EDSMB's review of the rate of FDA-defined valvulopathy, Arena has been able to confirm that the statistical power calculations used in the design of the Phase 3 trial program to monitor patients for increased risk of developing valvulopathy are justified. The findings from the month-12 review build on the EDSMB's September 2007 review that evaluated echocardiograms after 6 months of dosing.

"This critical milestone assessing month-12 echocardiographic data strongly supports lorcaserin's cardiovascular safety profile. We believe that this exposure duration, even under a conservative interpretation of the literature, would have been sufficient to observe a fenfluramine like effect on heart valves if present. BLOOM's primary echo endpoint is based on the month-12 data," said Jack Lief, Arena's President and Chief Exe
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Arena Pharmaceuticals Announces Public Offering of Common Stock
3. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
4. Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
8. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
9. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
10. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... RealtyShares ... connecting accredited and institutional investors to real estate investment opportunities nationwide, today announced ... demand from both investors and sponsoring real estate companies. , These ...
(Date:9/3/2015)... ... September 03, 2015 , ... The Linda Hall ... the surface of a comet, the IceCube observatory at the South Pole, and the ... , The Fall Lecture Series for the world's foremost independently funded research library devoted ...
(Date:9/3/2015)... New York, New York (PRWEB) , ... September 03, 2015 , ... ... chief of the Division of Trauma, Burns, Critical and Acute Care at NewYork-Presbyterian/Weill Cornell ... Medical College. , Dr. Winchell is a nationally renowned expert in care for the ...
(Date:9/3/2015)... ... September 03, 2015 , ... Atlantic ... virtual conference, “Proven Pharmacy Benefit Strategies for a Rapidly Changing Marketplace.” In this ... Scripts and Milliman, will discuss how plan sponsors are adopting bold, innovative strategies ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ProScrub is a ... back & forth, flicker, repeat, and custom speed effects without the use of keyframes. ... speed of effect. ProScrub tools are perfect complements to energetic video productions. ...
Breaking Medicine News(10 mins):Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 2Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 4Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 5Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 2Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 3Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 4Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 5Health News:Speakers for Upcoming AIS Virtual Conference on Pharmacy Benefit Strategies Include Executives from CVS Health, Express Scripts 2Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2
... -- BMP Sunstone,Corporation (Nasdaq: BJGP ) ("BMP ... to release first quarter 2009 financial results on,Monday, May ... The Company will hold a conference call ... first quarter 2009 results. Listeners may access the ...
... Technology Used in Cimzia(R) Through Exclusive Nektar-UCB CollaborationSAN ... NKTR ) confirmed today UCB,s announcement ... has approved Cimzia(R) (certolizumab pegol), the only PEGylated ... of adult patients with moderately to severely active ...
... -- Treating a common heart rhythm disorder by burning ... drug treatments, a major international study has found. , ... 63 percent of patients with an irregular heartbeat called ... or symptoms. By comparison, only 17 percent of those ...
... Allscripts, Cisco, Citrix, Dell, Intel, Intuit, Microsoft Corp., ... U.S.CHICAGO, May 14 Allscripts today announced the ... who are partnering to educate 500,000 U.S. physicians ... Reinvestment Act (ARRA) of 2009. The Act ...
... Anpath Group, Inc. (OTC Bulleting Board: ANPG), ... (ESI) and its distributor partner, Minntech Japan Corporation, ... 36th annual meeting of the Japanese Society of ... meeting was attended by over 4,000 medical professionals. ...
... Nile Therapeutics, Inc. (Nasdaq: NLTX ), a company ... patients, today announced its first quarter financial results for 2009. ... Food and Drug Administration (FDA) had placed all clinical studies ... a letter sent to Nile, and in a follow-up teleconference, ...
Cached Medicine News:Health News:BMP Sunstone To Report First Quarter 2009 Financial Results 2Health News:Nektar Announces UCB's Cimzia(R) Approved by U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 2Health News:Nektar Announces UCB's Cimzia(R) Approved by U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 3Health News:Heating heart with catheter better than drugs for common heart rhythm disorder 2Health News:Heating heart with catheter better than drugs for common heart rhythm disorder 3Health News:Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records 2Health News:Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records 3Health News:Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records 4Health News:Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records 5Health News:Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records 6Health News:Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records 7Health News:Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records 8Health News:Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records 9Health News:Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records 10Health News:Anpath Group, Inc. Distributor Introduces Products at the Japanese Society of Intensive Care Medicine Annual Meeting 2Health News:Nile Therapeutics Reports 2009 First Quarter Financial Results 2Health News:Nile Therapeutics Reports 2009 First Quarter Financial Results 3Health News:Nile Therapeutics Reports 2009 First Quarter Financial Results 4
(Date:9/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/sd9xxh/radiology ) ... Systems Market by Type, Deployment Mode, End User and ... report to their offering. The ... Million 2014, and is projected to reach $722.7 Million ... to 2019. The global radiology information ...
(Date:9/3/2015)... Sept. 3, 2015  Four financial reasons to ... white paper released by Leaf Healthcare, Inc . ... Research & Quality (AHRQ), pressure ulcers cost ... annually . In addition to direct treatment related ... penalties, and negatively impact hospital performance metrics. On ...
(Date:9/3/2015)... DUBLIN , Sept. 3, 2015 ... the addition of the "Investigation Report on ... offering. Thyroid hormones (TH) have ... babies or younger ones. Without thyroid hormones mainly ... and reproductive organs, even the growth hormone (GH) ...
Breaking Medicine Technology:Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 2Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 3Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 2Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 3Investigation Report on China's Levothyroxine Market, 2010-2019 2
... Nov. 29, 2011 Uptake Medical® today announced the ... lung volume reduction in a patient with severe emphysema. ... endoscopic lung volume reduction system for the treatment of ... without leaving foreign materials in the lung. The patient ...
... IRVING, Texas, Nov. 29, 2011 A new study in ... has uncovered a novel mechanism that cancer cells may use ... "Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T ... Moffitt Cancer Center in Tampa, Fla., shows that a specific ...
Cached Medicine Technology:Uptake Medical Announces First Commercial Use of InterVapor for Patients With Severe Emphysema 2Uptake Medical Announces First Commercial Use of InterVapor for Patients With Severe Emphysema 3New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System 2New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: